Background: Fever upon return from tropical or subtropical regions can be caused by diseases that are rapidly fatal if left untreated. The diff e rential diagnosis is wide. Physicians often lack the necessary knowledge to appropriately take care of such patients.
Background
Today, more and more people are crossing borders, either temporarily as tourists or permanently as migr a n t s . Tr ave l e rs who move into different climatic zones are often exposed to pathogens not encountered in their own country, and they are usually fully susceptible to them. To u rists may fall ill after their re t u rn with diseases rare l y e n c o u n t e red by the health services of their home country. S i m i l a r l y, m i grants may become ill after arrival as a re s u l t of infections acquired before they left their own countri e s or during their tri p. Fever is one important and f re q u e n t symptom in travelers upon return from tropical or subtropical regions. 1, 2 Apart from specialists in travel or tropical medicine, physicians often feel uneasy when dealing with imported fever, because they do not have e x t e n s ive knowledge about tropical diseases, and they are confused by the wide differential diagnosis and the nu m e rous diagnostic tests potentially ava i l a bl e.M o re ove r, t h ey know that some tropical diseases can be rapidly fa t a l when not recognized and treated immediately, such as m a l a ri a , typhoid feve r,or meningi t i s . Little ev i d e n c e -b a s e d information exists to guide clinicians on which specific diagnostic tests to propose in a particular situation 3 and when to consider presumptive treatment. 4 Thus, there is considerable variation in the management of such c a s e s . 5 A computer program has been developed to assist p hysicians in the differential diagnosis of fever (G I D E O N, Global Infectious Disease and Epidemiology Network, San Francisco, CA). 6 It is an excellent tool for teaching and practical case solving, since it gives an exhaustive list of all possible diagnoses; however, it does not provide indication on the management of such cases (specific diagnostic procedures and treatment), and is not freely available for health professionals.
We there f o re decided to develop practice guidelines for the evaluation of fever in travelers and migrants in order to support decision making and improve the knowledge of physicians, using an evidence-based approach completed by a process of gathering explicit international expert opinion. To be useful for all,these guidelines are available free of charge on the website <www.fevertravel.ch>.
Objectives Physician's Perspective
The guidelines will help the physician in charge of a patient presenting with fever upon re t u rn from a tro p i c a l or subtropical region in the evaluation and decision m a k i n g , by providing evidence-based suggestions about: (1) asking relevant questions on the travel experiences and the health problems;(2) looking for specific signs; (3) deciding on which specific diagnostic test(s) to p e r f o rm ; (4) deciding whether it is appro p riate to pro p o s e presumptive treatment or not;(5) deciding on the need for hospitalization.
The guidelines are also aimed at improving knowledge about tropical diseases among physicians and other health care professionals.
Patient's Perspective
The use of the guidelines by physicians should help patients by reducing (1) morbidity (duration and seve ri t y of symptoms) and potentially mortality; (2) exposure t ou n n e c e s s a ry inva s ive pro c e d u res or drugs with potential adverse events;(3) unnecessary transfer to a specialized center or hospitalization. F i n a l l y, the use of a more rational approach should reduce costs.
Target Audience
G iven the large va riation in knowledge and practice of medical professionals about care for re t u rning trave l e rs p resenting with feve r, we have defined a target audience that includes primary care practitioners, specialists in i n t e rnal medicine,emergency care,and infectious diseases as well as begi n n e rs in travel medicine. The decision chart is not designed for experts working in reference or specialized tropical medicine centers.
Target Population
The guidelines should be useful for health professionals caring for travelers and migrants coming from a t ropical or subtropical re gion (i.e. ,w h e re the epidemiolog y of commu n i c a ble diseases is clearly different from the one of temperate climates) and complaining of fever. This is defined as a history of raised temperature or feelings of alternating hot and cold or chills, sweating,or headache or an axillary temperature of more than 37.5°C. This broad definition allows patients to be included who complain solely of symptoms that often accompany feve r. This was the case, for example,for 3% of malaria patients (mean value from several studies,rev i ewed in Genton and D'Acremont 7 ).Although migrants constitute a distinct population from re t u rning trave l e rs , we decided to include them as a target group for our guidelines since they have been exposed to the same agents and can pre s e n t ,t h e ref o re, similar diseases.We acknowledge that the pro b a b i l i t y of some diagnoses is either higher (e.g.,tuberculosis) or much less (i.e.,Katayama fever, Löffler syndrome),but is never equal to zero. Indeed, with globalization and considerable population movements, the physician in charge is not always awa re that migrants may have transited or lived temporarily in areas where diseases other than those present in their country of origin can be present. Moreover, although the prognosis of some diseases is d i f f e rent in migrants than re t u rning trave l e rs , the clinical p resentation at the onset of symptoms is the same, 8 -1 0 a n d the decision chart is therefore appropriate. Also, in the latter, we do not take into account the incidence of the diseases mentioned, which means that there is no re a s o n to make a distinction between returning travelers and migrants. So the results of the studies, and hence the ev i d e n c e,a re based on studies made of mixed populations. The guidelines are not designed for pregnant women, children less than 8 years old, immunocompromised p a t i e n t s , or patients with seve re underlying chronic disease. When the patient has already taken antimalarials or antibiotics, the algorithm should be used with caution.
Methods

Documentation Available
In a systematic review of the literature performed up to April 2001, we extracted publications from the National Library of Medicine database by a MEDLINE search using the keywords "fever + guidelines (or synonyms)" or "travel (or derivates) + guidelines (or synonyms)"or "fever + travel (or derivates)"or "fever + migrant (or derivates)". For several diseases (the majority of those mentioned in the decision chart), we searched using "travel + name of the disease". We also e x p l o red the C o ch rane Database of Systematic Reviews u s i n g "fever"as a search term,the HealthSTAR database using " f ever or trave l " , and the C u rrent Contents Clinical Medicine database using "fever + travel".Additional articles were selected from the reference list of some key papers.Two General structure of the decision chart. In the Initial Evaluation section of the algorithm (see Appendix), following a general warning on the necessity of malaria tests and on the restrictions of the algorithm to tropical or subtropical diseases (not autochthonous ones),a set of 18 main steps is listed. All steps should be dealt with one after the other. When the response to a step is yes or positive, the examining physician should look at the corresponding tree development,which is either on the initial evaluation pages for the first 4 steps ("any danger s i g n " ;" a ny bleeding sign, including petechiae"; " c o n t a c t with body fluids…," and " m a l a ria-endemic area") or on separate pages for the next 14 steps (Figures 1 to 14 in Appendix). When the response to a step is No or Negative, the next step should be considered.
The steps are structured as follows:the first 4 steps a re the assessment of parameters of the history or phy s i c a l examination that should lead to the decision of immediate hospitalization and management of the patient.The next 5 steps are a set of specific questions related to travel history. Then there are 8 steps asking about selected symptoms or signs, and a last step corresponding to 1 abnormal laboratory result. When all steps have been reviewed and none of the responses are Yes or Positive, the algorithm leads to a final box, which describes the appropriate case management. institutional guidelines were obtained directly from the authors (Guidelines for doctors, Hospital for Tropical D i s e a s e s , L o n d o n , u n p u blished data, 2000) and Ebnöther.
11 From the 1,709 titles retrieved, we selected 250 articles based on the title or, in case of doubt, the a b s t r a c t .Only one of the latter was presented as a guideline for fever in the international traveler. 12 Four articles consisted of randomized controlled trials, and 15 were prospective or case-controlled studies. The remaining documents included descriptive case series.These series were usually small and the discussion of the results was most often mixed with additional personal experience and opinions.
Drafting and Evaluation of the Guidelines
Based on the documents listed above and on our ow n experience, 4 we constructed a draft decision chart. For each step of the decision chart, we also documented the b a c k gro u n d ,c o rresponding level of ev i d e n c e,main points of debate, final proposals and grade of re c o m m e n d a t i o n . We compared our differential diagnosis with the one obtained after entering similar conditions, such as history, s y m p t o m ( s ) ,s i g n ( s ) ,l a b o r a t o ry va l u e ( s ) , in the G I D E O N software. 6 The guidelines and attached document were then reviewed by a first group of European experts (development panel), including 6 specialists in tropical and travel medicine from re f e rence centers or unive rs i t y outpatient clinics, 2 specialists in tropical medicine, working as private practitioners , 1 specialist in infectious diseases from a unive rsity center,and 2 specialists in general i n t e rnal medicine, working as private practitioners .T h ey all gave their views individually on the target population, the potential users,and the basic assumptions,and they made an appraisal of the format and content of the a l g o ri t h m .W ritten comments and proposals for changes were sent by mail by the experts of the development panel, and we prepared a second draft.
This draft was discussed in detail with a second gro u p of 15 international experts in travel and/or tropical medicine (assessment panel with members of all continents but Oceania), attending the 7th Conference of the International Society of Travel Medicine (CISTM) in Innsbruck,Austria,in June 2001.Members of this panel were invited,and provided with the draft documents in a d va n c e. After the meeting, t h ey gave written suggestions. We then elaborated a third draft. In a final step,the expert s of both the development and assessment panel we re aske d to evaluate the revised ve rsion quantitative l y, using a scale graded from 1 (extremely inappro p riate) to 9 (extre m e l y appropriate) for each step of the decision chart. Since several changes have been made in the next and final version due to convergent suggestions or important comments of the expert s , the grading of appro p ri a t e n e s s (grade of recommendation) and its variability (level of S t ru c t u re of the figures themselve s. A branching stru c t u re starts with either a clinical or paraclinical question (for which two or three answers are possible) or a list of one or more possible diagnosis(es) to consider. Diagnoses that should be considered but have already been mentioned in a preceding step of the decision chart ,w h e re a necessary condition is the entry criterion, are indicated at the bottom of the figure as a re m i n d e r;for example, in Figure s 5, 8, and 13, "malaria has already been considered in the Initial Evaluation section" (after "malaria-endemic area"). Some of the items (question or diagnosis) are associated with one or two condition(s), introduced by "if...", related to the travel history (generally the destination and/or the time from re t u rn [usually the last day of exposure] up to the first symptoms [Time RS] and/or the time from first exposure to the first symptoms [Time ES]) or, rarely, the presence of another symptom or sign. The list of questions or diagnoses leads finally to one of four decisions: (1) to perform specific investigations (sometimes after contact with a specialist in trave l / t ropical medicine); (2) to give specific tre a t m e n t (either presumptively or after documentation of the diagnosis); (3) to hospitalize the patient; (4) simply to consider the next step on the decision chart.
Some boxes in the figures have been shaded to indicate that,at this point,a physician with limited skills in the field (light) or any physician (dark) should consult a specialist in trave l / t ropical medicine.The choice of the t h reshold for such consultation was extensively discussed with private practitioners and other expert s .It will depend on the expertise of the user,and can only be an indication.
Notes on the Use of the Decision Chart
For an appro p ri a t e reading and use of the algori t h m , the following points should be kept in mind: 1. Only crucial clinical and laboratory parameters to consider for the management of a presumed or documented disease are mentioned. A p a rt from the malaria test and full blood count,investigations to be done in a patient presenting with fever are left at the discretion of the physician. 2. Except for malaria and schistosomiasis, no information on the follow-up after the first assessment of the patient is given. 3. To be useful, the laboratory results should be obtained within 24 to 48 hours after the initial visit (except for the malaria tests which should be obtained within 3 hours). 4. When a diagnosis is confirmed by a specific test, no further investigation is necessary, except in the presence of an atypical symptom or sign. 5. When a presumptive treatment is proposed, the l a b o r a t o ry tests for a re t ro s p e c t ive diagnosis are not mentioned in the figures.
6. When "ad hosp"is given to indicate hospitalization at the end of a figure, the patient should not be followed as an outpatient. For all other proposed attitudes, the decision to hospitalize the patient is left at the discretion of the physician in charge. 7. The list of the diagnoses proposed under the heading Consider is not exhaustive. It includes the most frequent diseases and the ones that can potentially be rapidly fatal. 8. Diseases with a very localized epidemiology are usually not mentioned; if none of the diagnoses mentioned is plausibl e,a specialist in tro p i c a l / t r ave l medicine should be contacted. 9. No estimation of the relative probability of each diagnosis in a given situation has been mentioned since no good incidence data exist. 10. Although very rare, some diseases have still been included (i.e. ,M a r burg disease or melioidosis), s i n c e they bear a high case fatality rate. 11. When there is a contraindication to the specific dru g proposed for treatment, alternatives should be discussed with a specialist. 12. When the reading of the entire algorithm leads to two or more different diagnoses,decisions and/or p re s u m p t ive tre a t m e n t s , all should be considered in parallel.When the situation is too complex (many symptoms or signs are present), a specialist in tropical/travel medicine should be contacted.
Use of the Chart in Different Countries
Some important points should be considered:
1. For the sake of clarity, most autochthonous diseases that would be considered in a nontraveler are deliberately not mentioned but should always be considere d in parallel to the tropical diseases. The guidelines may, however, need some refinements according to the country where they are to be used, since autochthonous diseases are by definition specific to the country. In addition,for some diseases,changes may be needed to bring the chart into line with the standard policy in a given country; for example whether patients with falciparum malaria should be hospitalized. 13 2. Autochthonous diseases are included when the incidence rate differs between trave l e rs / m i grants and the general population in the country where the chart is used (e. g . , human immunodeficiency virus [HIV], hepatitis A or B).
Computerized Version of the Decision Chart
In order to simplify and to widen the use of the decision chart,a computerized version is now available on the website <www.fevertravel.ch>.
Procedure for Updating the Recommendations
The senior authors of this publication (BG, BB) will be responsible for bringing the guidelines up to date in response to the emergence of new evidence or new diseases in the field of travel/tropical medicine. The literature review will be regularly updated,and changes to the guidelines will be made accordingly. A formal reassessment and revision of the guidelines will be made with a maximal delay of 3 years.
Recommendations
For each of the 18 steps, a short discussion is p resented in the paper, s u m m a rizing the ev i d e n c e -b a s e d information extracted from the literature, the level of evidence for the whole figure, the key points of debate about the content, the final proposals made for those points,and the grade of recommendation for the figure. The levels of evidence and grades of recommendation have been determined according to the Oxford Center for Evidence-Based Medicine scale (ve rs i o n , M ay 2 0 0 1 ) . 1 4 When studies on the main subjects of the figure had different levels, the best level was chosen.
Initial Evaluation of Fever (see Appendix)
Any danger sign. Whatever the medical problem of the patient, specific signs known to be associated with an increased risk of death should lead to immediate hospitalization.Some signs have been shown to carry a bad prognosis for diseases rapidly lethal in a febrile patient upon re t u rn . These are, a ny degree of neuro l ogic impairment with meningitis or malaria and respiratory distress with malaria. 15 • Level of evidence: 2b • Grade of recommendation: B Any bleeding sign, including petechiae. Imported cases of hemorrhagic fever are very rare:from 1984 to 1998, only 3 cases of the contagious species were notified in the United Kingdom 16 ; from January to August 2000, 5 cases of Lassa fever were reported in Europe. 17 Because some of the hemorrhagic fevers are highly contagious and have a high mortality rate, it is of prime importance to rapidly rule out the diagnosis of hemorr h a gic fever in a patient upon re t u rn . The viruses causing Crimean-Congo, Ebola, Marburg, and Lassa fever are those for which a nosocomial amplification (person-toperson transmission) has been proven. The decision to isolate the patient, obviously after discussion with an e x p e rt , must be the first action. T h e re is a consensus that these diseases should only be considered when the time from the end of exposure (usually return) up to the first symptoms (Time RS) does not exceed 3 weeks. The major debate is about the minimal conditions, which make it reasonable to consider these diagnoses. One criterion is the country, or even better the area,visited. C o n s i d e ring a diagnosis of hemorr h a gic fever in travelers coming from regions with a recent epidemic is certainly not enough.Considering all places known to be endemic is feasible for Crimean-Congo (parts of A s i a , Eastern Europe, East-, West-and South Africa),Ebola, and Lassa fever (a few sub-Saharan A f rican countries 1 8 ) , but not for Marburg viru s , which is present in too many countries.
Each temperate country has its own policy,but these are often considered impractical by the physicians concerned,because where the criteria are wide, a huge number of patients would meet them and thus be u n n e c e s s a rily isolated. F u rt h e rm o re, since the pro c e d u re s for isolating patients and their body fluids are time consuming,the patient might be left with no treatment of any kind for a long period of time and die of a rapidly lethal disease other than a hemorrhagic fever, such as m a l a ri a . The international expert panel found it re a s o n a ble to re s t rict the measures of isolation to specific p a t i e n t s ,i . e. , those with fever and hemorr h a gic signs who had come in the last 21 days from an area where cases of viral hemorr h a gic fever have been re p o rted in the last 5 ye a rs . For those patients,immediate contact with expert s should be made. A pre s u m p t ive treatment for fa l c i p a ru m malaria should also be strongly considered.
• Level of evidence: 5 • Grade of recommendation: D Contact with body fluids of a person or animal potentially i n fected with Cri m e a n -C o n go, E b o l a ,M a r bu r g, or Lassa fe ver viru s. Since hemorr h a gic signs are not always pre s e n t , viral hemorrhagic fever should also (and perhaps p ri m a rily) be suspected in the case of a history of contact with body fluids of a person or an animal potentially infected with one of these viru s e s ; for example, a biolog y student returning from Côte d'Ivoire with Ebola after having assisted in the dissection of a monkey. 19 • Level of evidence: 5 • Grade of recommendation: D M a l a ria-endemic are a . A ny febrile traveler (as defined previously) coming back from an endemic area (if the Time ES is at least 6 days) should undergo all available tests for malaria (at least a thin smear; an additional thick smear is very useful to increase sensitivity, and a rapid antigen test to speed up availability of the result).After long discussion, the experts in travel medicine agreed that the results should be obtained within 3 hours.As soon as one of the tests is positive and whatever the species of h i s t o ry of swimming itch just after bathing was found only in 36% of 25 travelers in a case series recollected during 15 ye a rs . 2 6 The endemic areas for schistosomiasis are we l l defined. 27 Many travelers have been infected after swimming or diving in Lake Malawi 2 5 ; 2 8 . The incubation period for Katayama fever ranges from a minimum of 2 weeks (Time ES) to a maximum of 12 weeks (Time RS). 29 In the studies mentioned,the ranges were 14-63 days 23 and 15-60 days.
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Diagnosis of schistosomiasis. Since the majority of c o n f i rmed cases of Katayama fever have no physical signs apart from fever (9 of 16 patients in Doherty and c o l l e a g u e s 2 4 ) , the diagnosis is generally made on the basis of a combination of conditions, i.e., history of recent e x p o s u re + n e g a t ive malaria slide + e o s i n o p h i l i a .E o s i n ophilia is more sensitive than serology early in the course of Katayama fever (14 of 16 versus 4 of 16, respectively, at the time of admission 2 4 ) . Combining both tests incre a s e d the probability of confirming the diagnosis at an early stage.When both tests are initially negative, but schistosomes are indeed pre s e n t , an additional eosinophil count p e r f o rmed 6 days later will certainly be eleva t e d .S e a rc h i n g for ova in stools or urine is not useful in Katayama feve r; in the cases described by Visser and colleagues, 2 3 the firs t egg appeared 45 days after exposure. Treatment of confirmed schistosomiasis. Since acute schistosomiasis is a self-limited condition with nonspecific symptoms and signs,it is often misdiagnosed as a viral illness and left untreated. Some patients may eventually receive treatment because of a symptomatic chronic phase but others (probably the majority) will n ever be tre a t e d . N eve rt h e l e s s , complications of schistosomiasis in travelers have seldom been reported, probably because the parasite load is usually light in travelers.One case of late complication in a traveler was reported namely a dorsal myelitis that developed 1 year after exposure and re s o l ved completely with tre a t m e n t . 3 1 Some physicians,therefore, suggest that patients should be treated with praziquantel at an early stage to prevent neurologic sequelae. 32 However, early treatment often leads to transient exacerbation of the symptoms of K a t ayama fever or even to seve re allergic re a c t i o n . 3 3 T h e m a j o rity of experts in tropical medicine, t h e re f o re, a d v i s e administration of corticoids during the acute phase 3 4 a n d to wait until recovery (and generally until confirmation of the diagnosis by positive sero l ogy) to give praziquantel (or repeat the dose of praziquantel if it has been given already).New data on the efficacy of artemether against the early stages of infection may lead to a change in the therapy of Katayama fever. 35 • Level of evidence: 4 • Grade of recommendation: C Plasmodium is (since mortality has been documented for all species),the physician should carefully assess the patient and decide whether hospitalization is re q u i re d ,f o l l ow i n g the national or local policy. In countries were hospitalization for fa l c i p a rum malaria is not mandatory, o u t p a t i e n t management is possible after exclusion of symptoms and signs associated with a bad prognosis. 20 A list of clinical and laboratory criteria for hospitalization has been validated in a prospective study in an outpatient clinic in Switzerland and can be used for guidance. 13 The m o s ta p p ro p riate treatment (depending on the degree of severity, the species and density of parasites, the origin of infection, the potential contraindications, and the standard national policy) should be given, and a close clinical and parasitologic follow-up insure d .M a l a ria tests should be repeated every 12 to 24 hours,at least twice 21 when they are initially negative and no clear alternative diagnosis can be made. 3 A frequent pro blem is that malari a test results are only available after a long delay, mainly because of the lack of experience of microscopists in western laboratories.The expert panel considered that, when the delay exceeds 3 hours and no other diagnosis is documented, oral treatment should be given on p re s u m p t ive gro u n d s ,p rovided the probability of malari a is high,that is,in the presence of an enlarged spleen,or a platelet count <150 ǂ10 9 /L or an hemoglobin level <12g/dL (likelihood ratios for a positive diagnosis of malaria of 13.6, 11.0, and 4.6 respectively). In a re t ro s p e c t ive study of 595 asymptomatic long-term travelers to schistosomiasis-endemic areas,19% of those who reported frequent contact with fresh water, 13% of those who occasionally had contact and 5% of those who reported no contact at all were found positive by enzyme-linked immunosorbent assay (ELISA). 22 In an outbreak among 29 travelers,only one who had not been swimming remained seronegative. 23 In 16 cases of Katayama fever, all had swum in water known to contain schistosomes. 24 In a cross-sectional study of expatriates and tourists near Lake Malawi (a place of very high endemicity), the 1-day absolute risk of acquiring schistosomiasis was between 52 and 74%. 25 A Conditions sugge s t ive of leptospiro s i s. Infected indiv i d u a l s usually have a history of swimming,rafting, or wading in fresh surface water. 36, 37 In a study of 32 confirmed cases in travelers,all but one had had contact with water (21 had participated in a rafting tour 38 ).Risk factors for contracting the disease during rafting were ingestion of water or immersion underwa t e r. 3 6 Other possible sourc e s of contamination are contact with dogs, farming, or gardening in contaminated soil. 39 In a study in The Netherlands, autochthonous cases occurred in people working in the fields, whereas travelers had caught it through leisure activities involving water. 40 Since leptospirosis is a common cosmopolitan zoonosis found in virtually every country (see GIDEON software 6 ),no definite endemic area can be defined.
In a study of an outbreak among travelers, 36 the median time from the first day of exposure to the first symptoms was 12 days.In a recent outbreak,involving p a rticipants in the Ecochallenge 2000, the maximum time from the first day of exposure and first symptom was 23 days.
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D i agnosis of leptospiro s i s.
Beside the history of exposure, the key features leading to a suspicion of leptospirosis are the presence of jaundice (see Fig. 5 ) ,c o n j u n c t ival suffusion, or mild live r / renal impairm e n t . Each of these conditions is present in only about half of the patients, but conjunctival effusion is the most specific. 42 The earlier the patient presents in the course of the disease, the less likely is the presence of specific symptoms.
Blood cell count is unspecific and the diagnosis at this stage relies almost exclusively on specific diagnostic tests. 29 The microscopic agglutination test (MAT) comparing acute and convalescent sera is the gold standard, but its use is restricted to experienced laboratories,and the result gives only a retrospective diagnosis. 37 A blood c u l t u re taken rapidly after onset of symptoms may become positive, but the spirochete will take 1 or more week(s) to grow. In the course of the disease, the sensitivity of the d i f f e rent altern a t ive tests will va ry considerably accord i n g to the time between onset of symptoms and collection of sample; M AT with a titer ǈ1:100 (threshold that may have poor specificity for recent infection) is overall the b e s t . A case-control study in Les Seychelles (case definition: leptospirosis confirmed by a fourfold increase in acute/ c o nvalescent level of antibodies by MAT, or by a positive polymerase chain reaction [PCR] at any stage) showed that during the first 4 days of symptoms,4% of indirect hemagglutination assay s , 12% of dipstick assays detecting i m mu n og l o bulin M (IgM), 16% of ELISA,36% of MAT (with a titer ǈ1:100) and 38% of PCR were positive. 43 When the serum was taken between the seventh and the tenth day of symptoms,the rates changed to 29%,79%, 71%, 88%, and 46%, respectively. In another study in c o n f i rmed autochthonous cases in the United States, 7 1 % of the acute samples taken on the day of admission (mean time from onset of symptoms to the collection of the sample: 6.1 days, range 1-17) were positive using a commercial dipstick assay. 42 In the various studies, the specificities of these different tests we re similar (over 90%) and thus high enough for febrile travelers in whom leptospirosis is a rare disease. Tre atment of pre s u m p t ive or confirmed leptospiro s i s. I c t e ri c cases should be hospitalized immediately (see Fig.5 ). 42 Anicteric cases, provided they do not meet a criterion mentioned in the Initial Evaluation section ("Any danger sign"), can generally be managed as outpatients. Treatment should be initiated early in the course of the disease with dox y c y c l i n e, a m ox i c i l l i n , or penicillin because of the potentially fatal outcome of leptospirosis and because it has been demonstrated that antibiotics are efficient, especially when given during the first 2 days of sympt o m s .
3 6 , 3 7 In the study by van Crevel and colleagues, o n l y 44% received adequate antimicrobial therapy, but all recovered completely. 38 We recommend that,in a suspected case (fever + compatible exposure and incubation + conjunctival suffusion) that presents early (before the seventh day of symptoms), it is wiser to give a presumptive treatment straight away (and confirm retrospectively the diagnosis by MAT or by any other kind of serology) than to wait a few days for the serology result. When the patient presents after the seventh day of symptoms (and even in the absence of conjunctival suffusion),it is worth doing s e ro l ogy as its sensitivity will then be high enough to tre a t only when positive, particularly because the treatment becomes less urgent (the clinical manifestations being then mainly immunologically mediated).
• Level of evidence: 3a • Grade of recommendation: B Sexual Contacts with a New Partner or Injections Received (Fig. 3) Conditions sugge s t ive of pri m a ry HIV illness. The classical p resentation of pri m a ry HIV illness is easily mistaken for t ropical diseases (feve r, a d e n o p a t hy, r a s h ,f e a t u res of aseptic m e n i n gi t i s ,l e u c o p e n i a ,and/or thro m b o p e n i a ) . Pendle and S a c k s 4 4 found that a history of recent travel initially confused the diagnosis.Among the 11 patients investigated, 55% had a transient, macular or morbilliform rash, s i m i l a r to that of ri c kettsiosis or arbov i ro s i s . The most consistent and specific sign was the presence of a palatal enanthema.
The key feature to suggest acute seroconversion illness is a history of possible exposure to HIV, but patients a re sensitive about giving such inform a t i o n , and it is often omitted. Pendle and Sacks reported that the incubation period ranged from 6 to 56 days. 44 However, very often a traveler who takes risks of getting HIV while abroad also takes risks in his own country. 45 No Time RS is therefore indicated. D i agnosis of pri m a ry HIV illness. Since sero l ogy is often negative at this stage, the diagnostic criterion is antigen positivity (p24), in the absence of clinical features of a c q u i red immunodeficiency syndrome (AIDS). R eve rs e transcription (RT)-PCR is a complementary option when p24 is negative, but cannot be systematically recommended because of its cost.This test is left at the discretion of the attending physician,depending on the financial resources of the patient. In the series of 11 patients investigated by Pendle and Sacks,6 had sero l ogi c tests positive for a recent infection with another agent (3 rickettsia,1 Coxsackie virus,1 mumps,and 1 mycop l a s m a ) . 4 4 Whether these results re p resented anamnestic responses to an acute HIV infection (polyclonal re s p o n s e to B cell stimulation) is unclear, but they may serve furt h e r to confound the diagnosis.
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Management of primary HIV illness. Since patients are highly contagious during the acute illness,it is essential to brief them in order to avoid further transmission and investigate the sexual partner(s).Although not formally proven,some evidence exists to support rapid initiation of tritherapy. 46 • Level of evidence: 3b • Grade of recommendation: B Consumption of Raw Dairy Products and Symptoms for more than 7 days (Fig. 4) At present most of the reported cases of brucellosis are imported and associated with the consumption of dairy products. 47, 48 The clinical presentation is rather unspecific (except in case of bone or joint involvement) and generally subacute.The diagnosis is often made after several days or weeks of fever (undulant fever),once all other causes have been excluded 4 7 ;documentation is done by serology or prolonged blood culture during 7 to 10 days. 49 Since brucellosis is a rare cause of fever in travelers, and because the treatment includes a combination of antibiotics for at least a month,a laboratory confirm a t i o n should be obtained before starting therapy. H oweve r,t h e earlier the diagnosis is suspected and the specific inve s t igations are initiated, the lower is the risk of serious acute or chronic complications.
Another possible disease associated with consumption of raw dairy products,seen more often in migrants than in short -t e rm trave l e rs , is M y c o b a c t e rium bovis i n f e c t i o n (accounting for 1-3% of all tuberculous disease). 50 This infection is expressed more often in extrapulmonary sites (cervical and mesenteric nodes, the peritoneum, and the genitourinary tract) than are other infections due to Mycobacterium tuberculosis complex.In San Diego, over a 1 2 -year peri o d , up to 50% of the patients presented with e x t r a p u l m o n a ry disease.
5 0 The pro p o rtion of transmission by ingestion of unpasteurized milk versus aerogenous transmission is not known.
• Level of evidence: 4 • Grade of recommendation: C Jaundice (Fig. 5 51 although the incidence is declining due to extensive vaccination.
In the absence of other specific or danger signs,the result of serologies for viral hepatitis should be awaited before considering another diagnosis.When the results for all hepatitis viruses are negative, the patient should be hospitalized to be carefully investigated for tropical and nontropical causes. The second most common cause is malaria. When a patient with malaria presents with jaundice, the parasitemia will usually be high enough to be detected by microscopy.
Fever and jaundice (often in the context of mild live r impairment) are signs found in various tropical infections, 52 but are generally associated with other major symptoms or signs mentioned in the other figures of the algorithm.This is the case for amebiasis and fascioliasis, which are characterized by abdominal pain and/or liver e n l a r g e m e n t / t e n d e rn e s s ; ri c ke t t s i o s i s , in which jaundice is a sign of severe advanced disease;trypanosomiasis,in which a chancre is found;Lassa fever; Rift Valley fever; and dengue hemorrhagic fever, in which jaundice is accompanied by severe liver impairment. 51 Other diseases are associated with fever and jaundice only. 1. Typhoid feve r: in one study,30% of children pre s e n t e d with jaundice. 53 2. Yellow fever: one imported case presented with jaundice as the first specific symptom (on the fourth day after symptoms onset). 54 Another imported case had sudden onset of fever associated with one episode of hematemesis as the only specific sign. This patient was suspected of having viral hemorr h a gic feve r, a n d all appropriate measures were taken. The jaundice appeared on the third day. 
In a series of 159 cases of confirmed leptospirosis (37% of which we re of the ictero h e m o rr h a gic serova r ) ,5 2 % had jaundice. 40 In another, including 32 cases (only 4 of which were of the icterohemorrhagic serovar), 25% had jaundice. 38 A case of icteric leptospirosis should be hospitalized immediately, generally in the intensive care unit for close management of the associated renal insufficiency. 42 4. Relapsing feve r: l o u s e b o rne relapsing fever often leads to impairment of liver function and jaundice; 23% in an Ethiopian study of an outbreak (there is no i n f o rmation in trave l e rs ) . 5 6 It may occur in tickborn e relapsing fever but not as commonly; it was present in 10% of confirmed cases reported in the United States and Canada. Rashes can be roughly divided into petechial or maculopapular. When the rash is petechial, the patient should be considered as having a bleeding sign and be hospitalized as mentioned in the Initial Evaluation section ("Any bleeding sign including petechiae").
Rash is a sign found in va rious tropical infections,
among which only those that can manifest themselves with fever and rash are listed in Figure 6 . In the other i n f e c t i o n s , rash is associated with major symptoms or signs mentioned in other figures of the algori t h m :l e p t o s p i ro s i s will be suspected from the history (see Fig. 2 ); plague, a n t h r a x , or trypanosomiasis are associated with an eschar or a chancre (see Fig.7 );bartonellosis can be associated with a maculopapular rash,but the only type that is not autochthonous (the South A m e rican one) is a septicemia without any rash;HBV has other major clinical criteria ( F i g s .5 ,1 2 ) , as does histoplasmosis (Fig. 8 ) . The possibility of a drug reaction should not be omitted in trave l e rs who a re prone to take self-administered drugs during their tri p. Several important diagnoses should be considered:
• dengue • rickettsiosis • typhoid • relapsing fever • primary HIV illness
Conditions suggestive of dengue fever. Dengue fever is endemic or potentially endemic in more than 100 countries, i.e., in the greater part of the tropical and s u b t ropical are a s . It is now re c ognized as a frequent disease in trave l e rs ,p ro b a bly underdiagnosed because of the poor specificity of its clinical presentation.In a study among Israeli travelers to Southeast Asia, the attack rate of symptomatic disease (defined as febrile illness with positive antidengue IgM) was estimated at 3.4 of 1000 (the median length of trave l , which is cru c i a l , is unknow n ) . 5 8 R e p o rt s of the disease in travelers frequently mention it being acquired in Thailand 59 (especially between March and July 58, 60 ), India, or the Caribbean islands, 61 
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The percentage of confirmed cases among suspected cases depends highly on the inclusion cri t e ri a . In the study by Jelinek and colleagues,a suspected case was defined as a patient returning from an endemic area and having either fever + arthralgia/myalgia + headache or rash; among the latter, only 7% had a serologically confirmed recent infection. 6 3 It was not specified whether a negative blood slide for malaria was an inclusion cri t e ri o n . In the study by Shirtcliffe and colleagues, 25% of all the diagnostic tests performed for suspected cases of dengue fever (included retrospectively and without defined criteria) were positive. 62 Magill and colleaguesreviewed the Centers for Disease Control and Prevention (CDC) re p o rts from 1986 to 1995 and showed that among 1,377 samples of suspected cases, dengue was confirmed in 21% of them. 39 None of these studies was designed to determine the predictive factors for dengue. Only Shirtcliffe and colleagues compared the clinical presentation of the serologically positive patients with the negatives ones, and they found no difference. 62 The rash is classically described as macular or maculopapular and localized on the tru n k , the limbs, p a l m s ,a n d soles. 64 However, in practice, the rash is often atypical. In travelers,a rash was present on admission in 33% 62 to 59% of the cases. 6 1 , 6 5 The fact that the rash is inconstant, delayed,and unspecific in dengue fever means that this sign is of limited value for the diagnosis. 64 A more specific symptom is retroorbital pain, 39 but in the studies, this symptom is not distinguished from general headache, and its likelihood ratio cannot therefore be estimated.
Thrombopenia or liver function abnormalities are frequently reported (47% had thrombopenia and 27% abnormal liver tests in the study by Shirtcliffe and colleagues, 62 100% had thrombopenia in the study by Schwartz and colleagues 60 ) but are nonspecific. Diagnosis of dengue fever. The diagnosis is usually made re t ro s p e c t ively by sero l og y, c o m p a ring IgG levels in acute and convalescent sera (isolation of the virus itself by culture is very rare and the result is only obtained after 5 days). Serology is thus of little use in the acute phase and can even be falsely positive in trave l e rs previously va c c i n a t e d against Japanese encephalitis (JE) or yellow fever (YF). 66 N ew rapid tests that detect both IgG and IgM (e. g . , PanBio,Brisbane, Australia) have been developed. 67 In a study among trave l e rs in Israel,those with clinical dengue fever who could be followed daily from the onset of symptoms had detectable IgM between the fourth and the eighth day. 66 The control group (who had not traveled) were all IgM negative, whether vaccinated or not. For IgG, 17% and 44% of the group vaccinated for JE or Y F, re s p e c t ive l y, had a positive re a c t i o n , but usually close to the cut-off point (no IgG was detected in the unvaccinated control group). To help with positive diagnosis during the febrile episode,we recommend the use of these rapid tests instead of classical sero l og y,p rov i d e d the symptoms duration is greater than 5 days (and beari n g in mind that a negative test result does not allow one to definitely rule out the diagnosis). Management of dengue fever. As long as there are no bleeding signs, t reatment is not necessary. A documented diagnosis in the acute phase is mainly helpful to avoid f u rther investigations and prevent unnecessary tre a t m e n t against other diseases.
6 6 Patients should, h oweve r,be closely monitored to detect early signs of dengue hemorrhagic fever, that is the appearance of cutaneous or mucosal p e t e c h i a e, h e m o c o n c e n t r a t i o n , or hy p o p ro t e i n e m i a .
6 8 I n the presence of these abnormalities, they should be hospitalized immediately to re c e ive support ive tre a t m e n t . For the 289 confirmed cases declared to the CDC between 1986 and 1995,hospitalization was required in 1 to 2% of the cases. 3 9 A posteri o ri , the benefit to patients f rom knowing that their febrile illness was in fact dengue, is only to be aware of the higher risk of developing hemorrhagic features if they get infected again. Conditions suggestive of rickettsiosis. Mediterranean t i c k typhus due to R i ckettsia conorii accounts for the m a j o rity of imported ri c kettsiosis acquired in A f ri c a , 6 9 w h e reas typhus due to R i ckettsia tsutsugamu s h i is usually caught in A s i a / O c e a n i a .
7 0 A f rican tick bite feve r,due to the recently discove red species R i ckettsia afri c a e, is now often being re c ognized in trave l e rs coming back mainly f rom South A f rica and Zimbabwe. 7 1 P ro b a bl y, v i rt u a l l y all cases ori ginating from these re gions that we re d e s c ribed in the older studies, we re actually caused by
R . a f ri c a e, which was previously sero l ogically indisting u i s h a ble from R .c o n o ri i.
The incubation period is not clearly re p o rted in the studies of Marschang and colleagues;the range seems to be from 5 to 28 days. 70 The clinical presentation is nonspecific when the cutaneous manifestations are lacking.The rash was only present in 41% and the eschar in 50% of the cases in a series of 22 travelers with different types of rickettsiosis (mainly R.conorii). 70 In 119 travelers with African tick bite fever (R .a f ri c a e) ,a rash was found in 46% and an eschar in 95% of the cases. 7 1 In 645 Sicilian children with " f i è v re boutonneuse" (R. conorii), 96% had a rash and 72% an eschar. 72 The rash was mainly maculopapular, rarely petechial (1.4%) or vesicular (0.5%) and could often not be distinguished from rash of other origins.
Although not specific, headache was a frequent symptom (72% in Smoak and colleagues 73 or 68% in Cascio and colleagues 72 ) and was considered by the international experts of the panel as the second most important condition for suspecting rickettsiosis. More specific feature s , but often lacking, a re the history of a t i c k bite (61% in the study by Marschang and colleagues 7 0 a n d 9% in the study by Cascio and colleagues 7 2 ) and re gi o n a l lymphadenopathy (59% and 49%, respectively). In an o u t b reak among soldiers posted to Botswa n a , the authors attempted to calculate the odds ratios (OR) for various symptoms. 73 Lymphadenitis was the best predictor (OR=20, 95% CI 8-47), followed by fatigue, chills, mya l gi a , and headache.The laboratory parameters did not help much;leukocytosis was often not marked or even absent.
D i agnosis of ri ck e t t s i o s i s.
The sero l ogy at the start of the symptoms can be useful, provided IgM are quantified, which is not the case in most laboratori e s . In the studies o f M a rschang and colleagues and Cascio and colleagues 73% and 65%, respectively, had a first sample positive for IgM. 70, 72 The others developed IgM and/or IgG after a period of 1 to 4 weeks.Detection of IgG on the acute phase sera is of little help at the time of symptom onset because of the delay in occurre n c e.Among clinical cases in soldiers exposed to R. conorii in Botswana, IgG ( c o m p a ring acute and convalescent sera) was only useful for retrospective diagnosis.Even in this context, it was of limited sensitivity (24 of 39 and 32 of 36 sero c o nve rt e d as assessed by indirect immunofluorescent antibody test [IFAT] and Western blot, respectively).
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Treatment of suspected or confirmed rickettsiosis. Since confirmation of diagnosis is difficult in the acute phase and specific antibiotics are essential for good recovery, presumptive treatment with doxycycline is strongly recommended.In travelers,the outcome of rickettsiosis was clearly good,probably because the clinical features we re usually mild, and antibiotics we re give n . Among 22 travelers, 5 (23%) had to be hospitalized. 70 Among the latter, 4 had been misdiagnosed and mismanaged before referral to the specialized center. Conditions suggestive of typhoid fever. For travelers,the risk of acquiring typhoid depends on the country visited, their vaccination status, and/or prior immunity. The incidence is 10 times higher in India (1:30,000) and Nort h A f rica than in other tourist destinations. 7 4 , 7 5 In the United States,28% of the cases reported to CDC from 1985 to 1994 came back from Mexico and 25% from India. 76 Not much is known about the time from re t u rn fro m t r avel to onset of symptoms. Since studies are re t ro s p e c t ive and based on all reported cases,they include a mixture of domestically acquired and imported cases (defined as
having a history of travel to an endemic area in the p receding month).In one textbook,the incubation peri o d ranges from 3 to 56 days for Salmonella typhi and 1 to 10 days for Salmonella paratyphi. 29 The classical clinical presentation of typhoid is we l l k n ow n , with several key features that allow for ori e n t a t i n g the diagnosis (abdominal pain, c o n s t i p a t i o n , typical rash, re l a t ive bradycard i a , slight cough, l e u c o p e n i a ,l ow eosinop h i l i a ) .U n f o rt u n a t e l y, these features are often absent; f o r e x a m p l e,only 17% of 479 patients (adults and childre n ) 7 7 or 5% of 55 childre n 5 3 with proven typhoid fever had abdominal pain. D i a rrhea was much more frequent than constipation in the former study (56% ve rsus 3%) and eve n m o re so in children (77% in the latter study). The rash was present in 3% of the cases.We do not know any t h i n g about the routine laboratory findings in these studies. Diagnosis of typhoid fever. Since the diagnosis is often difficult to establish clinically, and the disease is potentially rapidly fatal,the results of blood cultures and stool cultures (useful even in the absence of diarrhea) are essential and should be obtained rapidly. In the re t ro s p e ctive studies, the diagnostic was made by blood culture for the vast majority of the patients (between 66% and 93% positive) or stool culture (between 35% and 54% p o s i t ive ) .
5 3 , 7 6 , 7 7 Those with a positive sero l ogy alone we re not considered as confirmed cases,because the specificity of this test is not sufficient.Serology is thus not recommended in febrile travelers. Tre atment of typhoid fe ve r. Clinical improve m e n t f o l l ows the rapid administration of antibiotics (quinolones, third-generation cephalosporins or azithromycin for a d u l t s , 78, 79 and third-generation cephalosporins or a z i t h ro mycin for childre n 8 0 , 8 1 ) .In the studies mentioned above, the overall case fatality rate ranged between 0.4 and 1.5%, the young children and the elderly being at greater risk. When there is a high index of suspicion o n clinical gro u n d s , and in the absence of another documented diagnosis, presumptive treatment should be s e riously considered while waiting for the stool and bl o o d culture results.
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Measles. Few data exist on the incidence of measles acquired abroad.During 1998 in the United States,100 cases were reported,of which 26% were imported. 82 In a study of 195 adults with fever, 83 as in a study of 31 c h i l d re n , 8 4 none was diagnosed with measles.In our study of 584 travelers with fever or malaise, measles was never diagnosed. 4 Conditions sugge s t ive of re l apsing fe ve r.Ve ry little ev i d e n c ebased information is available for relapsing fever in travelers,probably because of the low incidence (clearly lower than that of rickettsiosis) or at least because of underreporting.
The incubation period ranges between 2 and 18 days (see GIDEON software 6 ). Exposure to ticks was f requently re p o rted among autochthonous cases acquire d in northern United States and south Canada; 76% had either visited or lived in cabin or rural home, and 23% had a history of recent outdoor activity. 57 Patients with louseborne relapsing fever (due to B o rrelia recurr e n t i s) often present with a petechial rash, bu t during the first attack, the rash may be erythematous, resembling that of typhoid. 29 Regarding tickborne relapsing feve r,rash was found in 20% of confirmed cases reported in the United States and Canada, but the type of rash was not specified. 57 An eschar was only found in 3% of the cases.Only 23% of the confirmed cases were diagnosed at the first febrile episode; in the remaining o n e s , a history of relapsing fever was the key feature that led to the diagnosis.All other conditions found in these patients were unspecific. Diagnosis of relapsing fever. The gold standard is examination of a Giemsa-stained thick-blood film (obtained during a febrile attack) for spirochetes. This technique re q u i res some experi e n c e. C u l t u re is pri m a ri l y a research tool. Serologic tests are not widely available and are of limited value due to their lack of sensitivity and specificity. Tre atment of re l apsing fe ve r. Administration of tetracycline is important for full recovery of the acute episode and relapses but carries a high risk of Jarisch-Herxheimer reaction. The incidence of the latter seems to depend highly on the species of Borrelia involved and the magnitude of the bacteriemia;54% of the patients had this reaction in Dworkin and colleagues. 57 Treatment should be given after confirmation of the diagnosis and under close surveillance. P ri m a ry HIV illness. Acute HIV should be suspected in the presence of a rash, even in the absence of a history of sexual or intravenous exposure (see Figure 3) ,as the history is often unreliable, either because the patient omitted the information or questioning by the doctor was incomplete.
• Level of evidence: 4 • Grade of recommendation: C Ulcerative Skin Lesion (excluding Genitals) (Fig. 7) E s char or ch a n c re . Eschar and chancre are distinctive skin lesions but not always easy to re c ognize for a nonspecialist (see photographs in Fig. 7 ).
An eschar is typical of ri c kettsiosis (possibl y b o rreliosis) transmitted by ticks (for more discussion about rickettsiosis, see above). The only differential diagnosis for a true eschar is bubonic plague, which is still endemic in a few places in the wo r l d . It is ve ry unlikely for trave l e rs to catch bubonic plague,except if they have a clear history of close contact with re s e rvoir animals. Fo l l owing a short p ro d rome of flulike syndro m e,a suppurative lymphadenitis d eve l o p s , commonly in the gro i n . Pustules in the re gi o n drained by the affected nodes may ulcerate to form a n e s c h a r. One case,an A m e rican biologist who acquire d the disease during her job in Boliv i a , has been reported. 85 African trypanosomiasis is the only febrile disease that is associated with a true chancre. It is very rare in travelers:in 20 years,15 cases have been declared in the United States. 86 All have been acquired in East Africa, mostly during organized safa ri s . The only other significant risk factor was exposure to tsetse flies. The chancre was present in 67% of the 15 cases.A rash was found in 47% of them. Two cases, diagnosed with a delay of 10 and 19 day s ,re s p e c t ive l y, had central nervous system (CNS) invo l ve m e n t . Hospitalization was re q u i red for all cases. Recently, a cluster of 6 travelers who acquired t rypanosomiasis in the Serengeti National Pa r k , Ta n z a n i a , was notified to the TropNetEurop (2 of them reviewed in Ripamonti and colleagues 87 ).At least 4 of 6 patients d eveloped a chancre shortly before the onset of high feve r. In patients with specific information provided,the time between departing from the park and notification of a c h a n c re was less than a we e k .M a x i mum incubation time is generally considered as 3 weeks.
The acute phase of A m e rican trypanosomiasis often p resents with a chancre or ulcer, but is unlikely to be seen in a trave l e r, since the disease re q u i res prolonged exposure in a poorly constructed house infested with bugs, 88 and in a migrant who is already, if infected,in the latent or chronic phase.
It is sometimes difficult to distinguish a chancre or an eschar from an ulcer, and the etiologies mentioned below should then all be considered in the differential diagnosis. Ulcer. In a traveler, the most common cause of ulcer is a skin infection due to va rious agents (mostly Staphylococcus aureus),often complicating a wound or an insect bite, more rarely a specific tropical disease like cutaneous leishmaniasis (that otherwise would not provoke fever). Other causes mentioned in Felton and Bryceson are:(1) anthrax, which is seen in the context of professional exposure (outside the ve ry special context of bioterrorism) and for which a specialist in tropical/ infectious disease should be consulted;(2) histoplasmosis (the A f rican type),which is not associated with a systemic illness (and therefore fever) outside the context of i m mu n o s u p p ression (condition excluded from the guidelines); and (3) leprosy, in which ulcers are only seen at the late stage of the disease when other major signs are present. 52 • Level of evidence: 4 • Grade of recommendation: C Cough or Dyspnea (Fig. 8) Respiratory infections account for up to 11% of febrile illnesses in travelers. 89 Respiratory signs are mainly due to common organisms also found in nontravelers, but among the bacteri a ,t h e re is a higher pro p o rtion of atypical e t i o l ogi e s , such as legi o n e l l o s i s . For nonimmune trave l e rs (not for migrants), helminthes are important microorganisms,causing fever and acute respiratory manifest a t i o n s , either during the migration of the larvae thro u g h the lungs or through an immunologically mediated process, early in the cycle. An eosinophil count is thus essential to distinguish between bacterial and parasitic etiologies. Eosinophils greater than 500/mm 3 . No study mentions the time from the start or the end of exposure to the firs t symptoms for the different helminthiases. For ascari d i a s i s , Loeffler syndrome appears between 4 and 16 days after infection and for ankylostomiasis before the third we e k . 2 9 For stro n g y l o i d i a s i s ,w h e re autoinfection occurs ,p a r a s i t e s can pass through the lungs again at each new cycle and thus lead to respiratory symptoms at any time after infection. Paragonimus has a prepatent period of at least 3 weeks, 29 and lymphatic filariasis of at least 4 weeks. Schistosomiasis can sometimes present with respiratory symptoms during the acute phase, 44% of cough in the cases described by Doherty and colleagues, 2 4 4 cases with prominent pulmonary involvement described by Cook and colleagues. 33 In a retrospective study of 60 patients, 8 we re identified with re s p i r a t o ry pro blems that appeare d a few days after a febrile episode.
9 0 T h u s , these cases p resented a syndrome slightly different from Katayama f eve r, but pro b a bly also due to an immu n o l ogical pro c e s s . Management should follow the one mentioned in Figure  1 under skin contact with fresh or brackish water.
The presence of eosinophilia should lead to specific s e ro l ogic investigations (schistosomiasis, a s c a ri d i a s i s , strongyloidiasis,ancylostomiasis,and,depending on the destination of travel or the patient's country of ori gin and the time from return,lymphatic filariasis). 91, 91, 92 Unfortunately, cross-reactions of serologic assays for helminthiasis are frequent. A presumptive treatment is, therefore, often necessary. The choice between diethylcarbamazine (DEC), ivermectin, or albendazole should be discussed for each case,based on the probability of the d i f f e rent parasites. 9 3 The eggs (or larva for stro n g y l o i d i a s i s ) in stools do not appear before 8 weeks after infection with Ascaris, 3 weeks with hookworm, and 4 weeks with Strongyloides. Stool examination is thus less useful than serology during the acute phase. Eosinophils less than 500/mm 3 . According to Ellis, 94 a d ry cough in a traveler should lead to a chest X-ray,eve n in the absence of physical signs.In the presence of a history and a radiologic infiltrate compatible with communitya c q u i red pneumonia,the antibiotic of choice is a macro l i d e rather than an aminopenicillin,as stated in the Infectious Disease Society of American (IDSA) guidelines. 95 This is especially true in travelers because of the higher proportion of atypical pneumonia. 96 Another etiology to consider is tuberc u l o s i s ,m a i n l y in migrants or in people having lived abroad or having had professional exposure to affected persons.In a study based on tuberculin skin testing of 656 travelers,beside the duration of the stay abro a d ,p rofessional medical care was an independent risk factor for seroconversion upon re t u rn . 9 7 P u l m o n a ry histoplasmosis in trave l e rs is clearly associated with exposure to bats in caves 9 8 , 9 9 but can also sometimes be found after other type of contact like sleeping on the ground. Melioidosis can present as an infiltrate of upper lobes or cavities,similarly to tuberculosis. Travelers usually catch it in Southeast Asia, but recently several cases were imported from Bangladesh, I n d i a , and Pa k i s t a n .
1 0 0 The disease is also endemic in Pa p u a New Guinea and northern Australia.
For Hantav i rus pulmonary syndro m e,once re s p i r at o ry symptoms appear,the disease has such a rapid cours e that when patients are seen, they always present with re s p i r a t o ry distress leading to hospitalization in an intensive c a re unit (see " A ny danger sign"in the Initial Eva l u a t i o n section of the Appendix).
Mild cough can also be associated with typhoid fever (13% had cough in the study by Mathieu and c o l l e a g u e s 7 7 ) .In the absence of pulmonary infiltrate, t h i s diagnosis should be considered, even if abdominal pain is lacking. However, since the probability is low in this situation,documentation before treatment is advisable. Malaria can also present with a mild cough (13% in a rev i ew of several studies 7 ) , but has already been considered under "Malaria-endemic area"in the Initial Evaluation section.
Finally, pulmonary embolism is seen in travelers whose lower limbs have been immobilized for hours during a long trip.
• Level of evidence: 3b • Grade of recommendation: B Sore Throat (Fig. 9) Beside viral or bacterial pharyngitis,which is by far the most common cause of sore throat even in travelers, some tropical etiologies should be considered in particular situations. D i p h t h e ri a . Since trave l e rs are generally immu n i z e d ,a n d the disease is epidemic in places with poor health systems w h e re tourists seldom go, i m p o rted diphtheria is ve ry rare. The presence of the typical pharyngeal membrane is a key sign to define a probable case. 101 C o n f i rmation is done by culture or histopatholog y. Two cases imported from the Russian Federation and the
Ukraine are described in the Morbidity and Mortality We e k ly R e p o rt (MMWR).
1 0 2 Both patients had no known contact with a diphtheria patient. Vaccination status was unknown for the first patient;the second patient was fully va c c i n a t e d , which possibly prevented her from deve l o p i n g toxic complications. M a r burg virus disease and Lassa fe ve r. Although patients with other types of viral hemorrhagic fever can present with a sore throat,this sign is specific for Marburg virus disease and Lassa fever. Two of the 3 imported cases of M a r burg in South A f rica in 1975 had red and congested soft and hard palates.
1 0 3 When no clear history of contact exists (see "Contact with body fluids…" in the Initial E valuation section),the diagnosis is ve ry difficult to make when only fever, myalgia,or headache is present. After some days, hemorrhagic manifestations or severe renal and liver function impairment will appear and lead to the diagnosis. Primary HIV illness. As mentioned above (see Fig.3 ), the more consistent and specific sign was the presence of a palatal enanthema (11 of 11 patients in the study by Pendle and Sacks 44 ).
• Level of evidence: 5 • Grade of recommendation: D Abdominal Pain (Fig. 10) When signs of peritoneal irritation are present, management for acute surgical abdomen must be u n d e rt a ken by a surgeon, keeping in mind the possibility of ileal perforation due to typhoid feve r,colitic perforation due to amebiasis or rupture of an amebic liver abscess. O t h e r w i s e,typhoid fever is the first diagnosis to consider in an adult traveler with fever and abdominal pain ( p re s e n t in 17 to 34% of the cases 7 7 , 1 0 4 ) . In children,it is probably malaria,which is often characterized by gastrointestinal complaints (75% of 70 cases had either abdominal pain or diarrhea or vomiting 105 ). Another potential diagnosis, especially when the abdominal tenderness is located in the right upper quadrant, is amebic liver abscess. 106 To orientate the diagnosis, it is essential to consider the leukocyte count (leukocytes are rarely higher than 10 ǂ10 9 /L in typhoid fever without perforation and the mean is 16 ǂ1 0 9 /L in amebic liver abscess 1 0 6 ) and usually to do an ultrasound examination.
Felton and Bryceson report that many diseases can lead to abdominal pain. 5 2 A p a rt from the three diagnoses already mentioned,a wide range of bacteria or parasites of the intestinal tract can cause fever + abdominal pain, but almost invariably with some degree of diarrhea (see below).The other etiologies have other major features. Typhoid fever. Typhoid fever should always be suspected in the presence of fever and abdominal discomfort, regardless of the presence of other specific symptoms or of 63 patients with abscess 1 0 7
) .In particular cases (depending on size and peripheral location), p e rcutaneous drainage m ay be necessary both for amebic and pyogenic abscess. (Fig. 11) There is no study, and a fortiori no guidelines,on d i a rrhea with feve r. The most likely etiology in trave l e rs is bacterial gastro e n t e ri t i s .H oweve r,as diarrhea is the most common pro blem among trave l e rs , it may be difficult to know whether diarrhea is part of the disease or a dual infection.
Traditionally, typhoid fever in adults is considered to be associated with constipation rather than diarrhea. Some studies show the contrary (3% with constipation versus 56% with diarrhea in the study by Mathieu and colleagues 77 ). In children, diarrhea is frequent (77% in the study by Misra and colleagues 5 3 ) .M a l a ria may pre s e n t with diarrhea but,in a sample of adult travelers coming back with fever, this symptom was rather negatively associated with malaria. 4 When there is a history of previous antibiotic intake (often self-administered in t r ave l e rs ) , C l o s t ridium difficile should be suspected and the toxin searched for.
Bloody stools suggest the presence of a bacteria (primarily Shigella, also consider Escherichia coli 0157) or a m e b a . The symptom is also found in viral hemorr h a gi c fevers, but other major clinical features are required to suspect a case. It is very rarely found in malaria;among 441 adult trave l e rs with malari a , only 3 had bloody stools (reviewed in Genton and D'Acremont 7 ). T h e o re t i c a l l y, b a c t e ria cause diarrhea with a maximum incubation period of 7 days, except for Campylobacter (up to 10 days).In practice, symptomatic salmonellosis can occur after much more than 4 weeks.
Parasitic etiologies are rather rare,the most fre q u e n t being intestinal amebiasis. 1 1 0 -1 1 2 C ry p t o s p o ri d i u m is seldom found but can sometimes present with feve r. 1 1 0 ; 1 1 3 R e c e n t l y, a new cause of diarrhea upon re t u rn has been descri b e d , mainly from Nepal and South America; Cyclospora cayetanensis. 114 However, it is not clear how often fever is associated with this pathogen. 115 This microorganism should be considered at a later stage, that is, in cases of prolonged febrile watery diarrhea. 116 Giardiasis and chronic schistosomiasis are not associated with fever.
Other etiologies of febrile diarrhea (measles, legionellosis, relapsing fever, melioidosis, viral hemorr h a gic feve r, and anthrax) have other major clinical signs 5 2 and are not dealt with in this figure.
In the IDSA guidelines for the management of infectious diarr h e a ,t h e re is no mention of the usefulness of testing white blood cells or lactoferrin in the stools signs or vaccination status. When malaria has been ru l e d out, enteric fever is the most common cause of fever lasting 10 or more days. 3 When the leukocyte count is <1 0 ǂ1 0 9 / L , and after blood and stools have been obtained for cultures, q u i n o l o n e s 7 8 , 7 9 ( t h i rd generation cephalosporins or a z i t h ro mycin in childre n 8 0 , 8 1 ) should be given as p re s u m p t ive treatment for typhoid feve r, p a rticularly since quinolones would treat bacterial gastro e n t e ritis at the same time (see under diarrhea, Fig.11 ).When the leukocyte count is ǈ1 0 ǂ1 0 9 / L , an abdominal ultrasound examination should be performed to rule out an amebic liver abscess (see below). Amebic liver abscess. In a hospital in Japan,among 227 patients admitted for amebiasis, 69 (30%) had a liver abscess. 107 In these 69 cases,only a few had a history of p revious intestinal amebiasis.On clinical examination, 7 5 % had abdominal tenderness (we do not know whether it was localized or not),67% had hepatomegaly, and 44% had diarrhea (16% with bl o o d ) . In a rev i ew that mentions 4 case studies,including altogether 241 patients,pooled data show that 89% complained of abdominal pain, 7 3 % had right upper quadrant tenderness, and 29% had hepatomegaly. 106 The diagnosis of liver abscess is made in the presence of a typical liver lesion seen by ultrasound or computed tomography (CT) scan examination.The sensitivity of the ultrasound alone is not specified in the studies by Lee and colleagues or We i n ke 1 0 7 , 1 0 8 but another study showed that it is only slightly lower than that of CT scan. 1 0 9 Taking into account the higher cost and the lower availability of the latter, it should be restricted to cases with normal ultrasound results but high suspicion (i.e.,positive serology; very early presentation in which hepatic changes may not yet be visualized by ultrasound).
In practice, when the leukocyte count is ǈ10 ǂ10 9 /L, an abdominal ultrasound scan should be p e r f o rmed to look for a hepatic abscess.If this is positive, s e ro l ogy should be carried out for ameba. S e ro l ogy is ve ry sensitive in the case of extra intestinal amebiasis (94% in the study by Lee and colleagues 107 ) and is essential to determine the etiology of the abscess.Stool microscopy is much less sensitive (ameba was found in 45% of 69 p a t i e n t s , whether or not they had associated diarr h e a 1 0 7
) . Stool antigen detection tests are still less sensitive than serology in this situation. 106 These assays do not provide a definite confirmation of the etiology of the liver abscess but may give a reasonable justification to give a pres u m p t ive treatment with imidazoles and avoid an abscess puncture. When all results are negative, the most likely etiology is pyogenic, secondary to biliary tree infection, and appropriate investigations should be performed.At this stage, abscess puncture is essential to determine the exact etiology and decide on the right antibiotic (it should be noted that ameba were found in the pus in only 62% for the management of community acquired or trave l e rs ' d i a rr h e a . 1 1 7 T h e re is actually no sufficient evidence for their use and no expert consensus.
If the incubation period is less than 8 weeks, the etiology is very likely to be bacterial.Since both Shigella and S a l m o n e l l a (as intestinal salmonellosis or typhoid feve r ) can lead rapidly to a fatal outcome, it is wise to give p re s u m p t ive treatment with quinolones. 1 1 7 Stools should be collected for culture (and at the same time for p a r a s i t o l ogic examination) prior to the first administration of antibiotics, mainly to obtain an antibiogr a m .H oweve r t h e re is no reason to delay the latter if no stool is ava i l a bl e. N u m e rous studies in trave l e rs have shown that antibiotics reduce the duration of diarrhea, even in absence of f eve r. 1 1 8 , 1 1 9 The IDSA guidelines for the management of infectious diarrhea clearly recommend the administration of presumptive treatment with quinolones for travelers diarrhea (strength and quality of evidence A-I) and for febrile diarrhea (B-2). 117 Although resistance to quinolones is growing, especially for strains of S. typhi originating from the Indian subcontinent 120 and for Campylobacter from Southeast Asia, 121 these antibiotics remained active in vitro against most bacterial enteropathogens causing travelers' diarrhea. 112 Quinolones should still remain the drug of choice for empirical t reatment of trave l e rs 'b a c t e rial diarrhea in adults. A l t e rna t ive drugs could be azithro my c i n , which is also the dru g of choice in children,or possibly ceftriaxone, which is highly active against the enteropathogens but has the d i s a d vantage of re q u i ring parenteral administration. In the rare cases where the stool examination reve a l s the presence of a parasite (mainly amebiasis),a specific antiparasitical treatment should be introduced.
If the incubation period is greater than 8 we e k s ,t h e etiology is more likely to be parasitical rather than b a c t e ri a l . It is thus wise to wait for the results of the stool c u l t u re and parasitologic examination before deciding on the most appropriate treatment.
• Level of evidence: 1 • Grade of recommendation: A Hepatomegaly (Fig. 12) Almost all febrile diseases in returning travelers can produce some degree of hepatomegaly, especially in children.Depending on the etiology, hepatomegaly can be associated with splenomegaly,for example in malari a , which is a frequent cause of hepatosplenomegaly in febri l e travelers. Since the majority of the diseases causing hepatomegaly have other major signs, t h ey are considere d in other figures. Here, we consider only the diagnoses w h e re hepatomegaly is the prominent or the only clinical feature.
Since it is frequent in travelers,the first diagnosis to consider is viral hepatitis (see G I D E O N s o f t wa re 6 ) .W h e n the results of the liver function tests are compatible with this diagnosis, serology should be carried out rapidly, before performing other expensive investigations. The second diagnosis to consider is amebic liver abscess (see above for more details);67% of 69 patients 107 and 29% of 241 patients 106 had such a sign in two studies.Other than malaria,it is the only disease that should be treated rapidly (by aspiration in specific cases),in order to avoid rupture into the peritoneal or pulmonary cavity. .
Although much less common, two other diseases should be considered. Hepatomegaly and eosinophilia are almost always found. A specific image (moving parasites or crescent-shaped contents in the biliary tract) can be found by ultrasound (this was the case for 11 of 76 patients d e s c ribed in Richter and c o l l e a g u es 1 24 ) ,but in general only nonspecific biliary tract abnormalities are found (52 of 76 patients in the same study) and very rarely a liver mass. 125, 126 The diagnosis of certainty that allows a specific treatment to be initiated is obtained mainly by serology and sometimes by microscopic stool examination, although eggs appear only 3 to 4 months after the infection. 127 
2.
Visceral leishmaniasis:although less frequent than splenomegaly, hepatomegaly was present in 58% of 89 cases (the majority being autochthonous) i nF r a n c e. 1 2 8 We do not know whether some patients had hepatomegaly without associated splenomegaly.
• Level of evidence: 4 • Grade of recommendation: C Splenomegaly (Fig. 13) Enlargement of the spleen, often to a ve ry large size, is an almost constant feature in visceral leishmaniasis. T h i s diagnosis is suspected in case of pancytopenia and hy p e rg a m m a g l o bu l i n a e m i a . 3 9 The maximum incubation period reported is 4 years, 129 but the average is between 2 and 4 months. 29 Fever was present in 88% of all cases and splenomegaly in 100% of the children under 8 ye a rs and 80% of older children and adults. 28 As mentioned previously, splenomegaly had a high likelihood ratio (13.6) for a positive diagnosis of malaria (see under "malaria-endemic area").
• Level of evidence: 4 • Grade of recommendation: C Eosinophils greater than 500/mm 3 (Fig. 14) A large variety of helminths can cause fever and eosinophilia during the phase of invasion. The most frequent in travelers are schistosomes that have already been considered under skin contact with fresh or brackish water (Fig. 1 ) . The other important diagnoses to c o n s i d e r a re filarial infections, such as loiasis or lymphatic fi l a ri a s i s. Loa Loa is certainly the most frequent filaria in trave l e rs , and the history of transient Calabar edema after a trip to West Africa rapidly orientates the diagnosis (present in 100% of 26 imported cases 130 ). O n c h o c e rciasis is seen in long-term trave l e rs or in m i gr a n t s , 1 3 1 but is almost never associated with fever and has thus not been included. U n l i ke strongyloidiasis and a n c y l o s t o m i a s i s ,a s c a ridiasis does not induce fever in the absence of cough (in the context of Loeffler syndro m e, see Fig. 8 ) and is thus not mentioned here. F i n a l l y, t richinosis should be considered in the presence of mya l gi a .
When both serologies and stool examination are negative for all of these parasites, the tests should be repeated later.
• Level of evidence: 4 • Grade of recommendation: C
Discussion
To make these guidelines readable, we decided to focus on the diseases that are found only, or at least more often, in tropical and subtropical countries. This leads to an algorithm that is only part of the whole evaluation,and the resulting decision making for patients presenting with fever upon return or migration from these regions is incomplete. An algorithm that included all possible diagnoses would have been far too complicated and eve n i m p o s s i ble to create since it would have meant a decision chart for fever, an enterprise that nobody dared to do. Indeed all guidelines that deal with fever have focused on one particular aspect (e. g . , guidelines for the eva l u a t i o n of fever and infection in long-term care facilities, guidelines for the use of antimicrobial agents in neutropenic patients with unexplained feve r ) . This decision chart s h o u l d ,t h e re f o re,be seen as an additional tool to consider and rule out diagnoses that the nonspecialized phy s i c i a n s are often not familiar with.
The reasons to include migrants in the target population have already been discussed in the Methods section. We would just like to emphasize here that, although the two populations are clearly distinct, t h ey have not been separated in previous studies and that the evidence thus pertains to the mixture of the two populations. We acknowledge the urgent need to test both cohorts of travelers and migrants separately, and to i nvestigate whether the potential differences observed in guideline adherence would justify the need to have separate recommendations.
We believe that the choice to focus on tropical diseases and to mix the populations of travelers and migrants is justified for the sake of simplicity and safety. Simple and clear guidelines designed to assist physicians and patients in making appro p riate decisions may be more e f f e c t ive than nu m e rous and ve ry detailed ones. It is tru e that re l a t ively simple guidelines may be criticized as being incomplete and close to so-called cookbook medicine. This is a common criticism and must be weighed against the reality of medical practice and the potential usefulness of easily understandable recommendations.
The discussions with the assessment panel highlighted different opinions regarding the desirable complexity of the tree stru c t u re (i.e. , the amount of details) that should be provided for primary care physicians dealing with patients with fever coming from tropical countries.The less specialized the physicians we re,the more pleased they we re to have complete information to achieve a diagnosis and make a decision. The experts we re wo rried that too much detailed information might lead the primary care p hysician to make inappro p riate decisions.To accommodate these experts' dissensions, we agreed to flag the situations that need deeper knowledge for patient management. If we had targeted information only to p hysicians with little expertise in the field,we would have ended up with a tree with very few branches,almost all of them leading to the recommendation of contacting a travel/tropical medicine specialist. Such an approach would have ignored the great variability in the knowledge of pri m a ry care or emergency physicians and wo u l d h ave provided little further insight in the field.One may argue that including a great deal of information has resulted in charts that are too complex to be easily readable. This may be true when one looks at all the figures.But using the chart for a defined patient with a defined problem requires the reading of only 1 to 3 figures. Also the computerized version is much more convenient since the physician only opens the relevant figures.Interestingly, the primary care physicians in the panel of development experts did not perc e ive the chart as too complex to read and use; it was the specialists who argued for simpler figures. We believe that our concept allows greater flexibility than simpler figures in the use and implementation of the guidelines, but it pro b a bly does demand more responsibility on the part of the user. In our view,guidelines should be a support to help phy s i c i a n s to make decisions in situations that may be complex and, in the present case, not frequently encountered in the daily practice of primary care physicians. experts:
• 
